• Edward F. RyanJr.
Part of the Current Clinical Practice book series (CCP)


Rosacea is a common skin condition, of an unknown cause, that affects about 4–5% of the population. It is typically characterized by flushing and acneiform lesions. It is more common in women and can range from mild to disfiguring in severity. Treatments need to be targeted to the subtype and its main clinical manifestations. Exacerbations can also be related to certain behaviors like ingestion of warm beverages, spicy foods, temperature exposure, and exercise. Overall, it is a chronic condition that treatment is more directed at control than cure.


Rosacea Erythematotelangiectatic rosacea Papulopustular rosacea Phymatous rosacea Rhinophyma Ocular rosacea Cathelicidin Demodex Metronidazole Azelaic acid and Ivermectin 


  1. 1.
    Rosacea riddle now threatens more than 16 million Americans. National Rosacea Society; 1 Apr 2010.
  2. 2.
    Moustafa F, Hopkinson D, Huang K, Feldman S. Prevalence of rosacea in community settings. J Cutan Med Surg. 2014;19:149–52.CrossRefGoogle Scholar
  3. 3.
  4. 4.
    Moustafa F, Lewallen R, Feldman S. The psychological impact of rosacea and the influence of current management options. JAAD. 2014;71:973–80.PubMedCrossRefGoogle Scholar
  5. 5.
    Shim TN, Abdullah A. The effect of pulsed dye laser on the Dermatology Life Quality Index in erythematotelangiectatic rosacea patients: an assessment. J Clin Aesthet Dermatol. 2013;6:30–2.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Menezes N, Moreira A, Mota G, Baptista A. Quality of life and rosacea: pulsed dye laser impact. J Cosmet Laser Ther. 2009;11:139–41.PubMedCrossRefGoogle Scholar
  7. 7.
    Tan SR, Tope WD. Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life. J Am Acad Dermatol. 2004;51:592–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Wilkin J, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. JAAD. 2002;46:584–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Tan J, et al. An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Br J Dermatol. 2013;169:555–62.PubMedCrossRefGoogle Scholar
  10. 10.
    Tan J, Berg M. Rosacea: current state of epidemiology. JAAD. 2013;69:S27–35.PubMedCrossRefGoogle Scholar
  11. 11.
    Del Ross JQ, et al. Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea. Cutis. 2013;92:234–40.Google Scholar
  12. 12.
    Two A, et al. Rosacea: Part I. Introduction, categorization, histology, pathogenesis, and risk factors. JAAD. 2015;72:749–58; Baldwin HE. Diagnosis and treatment of rosacea: state of the art. J Drugs Dermatol. 2012;11:725–34.PubMedCrossRefGoogle Scholar
  13. 13.
    Aviv Barzilai A, et al. Cutaneous B cell neoplasms mimicking granulomatous rosacea. Arch Dermatol. 2012;148(7):824–31.PubMedGoogle Scholar
  14. 14.
    Holmes A. JAAD Potential role of microorganisms in the pathogenesis of rosacea. JAAD. 2013;69:1025–32.PubMedCrossRefGoogle Scholar
  15. 15.
    Steinhoff M, Schauber J, Leyden J. New insights into rosacea pathophysiology: a review of recent findings. JAAD. 2013;69:S15–26.PubMedCrossRefGoogle Scholar
  16. 16.
    Dirschka T, Tronnier H, Folster-Holst R. Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis. Br J Dermatol. 2004;171:259–66.Google Scholar
  17. 17.
    Lonne-Rahm SB, Fischer T, Berg M. Stinging and rosacea. Acta Derm Venereol. 1999;79(6):460–1.PubMedCrossRefGoogle Scholar
  18. 18.
    Mikkelsen CS, et al. Rosacea: a clinical review. Dermatol Rep. 2016;8:6387.CrossRefGoogle Scholar
  19. 19.
    Del Rosso JQ, Baum EW. Comprehensive medical management of rosacea: an interim study report and literature review. J Clin Aesthet Dermatol. 2008;1:20–5.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Van Auuren EJ, Fedorowicz Z. Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments. Br J Dermatol. 2015;173:651–62.CrossRefGoogle Scholar
  21. 21.
    Jesetus J. Dermatol Times. 1 Oct 2013.Google Scholar
  22. 22.
    Preshaw PM, et al. Modified - release subantimicrobial dose doxycycline enhances scaling and root planing in subjects with periodontal disease. J Periodontol. 2007;2(5):523–31.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Edward F. RyanJr.
    • 1
  1. 1.Bryn Mawr Skin & Cancer InstituteBryn MawrUSA

Personalised recommendations